Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
75.8M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$612M
-
Value change
-
-$16.3M
-
Put/Call ratio
-
0.02
-
Number of buys
-
67
-
Number of sells
-
-46
-
Price
-
$8.07
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q4 2024
155 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.8M shares
of 86.3M outstanding shares and own 87.82% of the company stock.
Largest 10 shareholders include Pfizer Inc (5.38M shares), Nextech Invest Ltd. (5.29M shares), BlackRock, Inc. (5.11M shares), VIKING GLOBAL INVESTORS LP (4.43M shares), VR Adviser, LLC (4.39M shares), ALKEON CAPITAL MANAGEMENT LLC (3.9M shares), Frazier Life Sciences Management, L.P. (3.89M shares), Column Group LLC (3.54M shares), EcoR1 Capital, LLC (3.42M shares), and VANGUARD GROUP INC (3.2M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.